Information  X 
Enter a valid email address

TempletonEmerg.Mkt. (TEM)


Monday 10 May, 2021


Directorate Change

RNS Number : 0738Y
Templeton Emerging Markets IT PLC
10 May 2021

10 May 2021



Templeton Emerging Markets Investment Trust PLC


Legal Entity Identifier: 5493002NMTB70RZBXO96


Board Appointment



Templeton Emerging Markets Investment Trust PLC (the "Company") announces that the Board of Directors have agreed to appoint Magdalene Miller   as a non-executive Director of the Company, with effect from 10 May 2021.


The Company discloses this information pursuant to Listing Rule 9.6.11.R and 9.6.13 R made by the UK Listing Authority. This disclosure is based upon information provided by such Director and has not been independently verified by the Company.


Mrs. Miller has no details to disclose pursuant to Listing Rule 9.6.13 R (2) to Listing Rule 9.6.13 R (6).


Mrs Miller is a former Investment Director with Aberdeen Standard Investments' global emerging market team. Based in London and Edinburgh, she spent 32 years managing listed equity portfolios, investing in Japanese, Asian Pacific and UK markets. In the 10 years before her retirement in 2018, she ran the Standard Life China Sicav, one of the top performing funds in its sector. A native of Hong Kong, Magdalene is fluent in Cantonese and Mandarin and has travelled extensively in China and Asia over the course of her career. She currently serves as a Non-Executive Director of Baillie Gifford China Growth Trust and as a trustee for an educational endowment fund and participates in volunteering work.




For further information please e-mail   temitcosec  or contact Franklin Templeton Client Dealer Services via e-mail at [email protected]    or via free phone 0800 305 306, +44 (0) 20 7073 8690 for overseas investors.




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

a d v e r t i s e m e n t